POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Missouri HB 1681 requires health plans to count third-party payments toward out-of-pocket maximums for drugs without generic substitutes

Original title: COST-SHARING UNDER HEALTH BENEFIT PLANS

Last action · February 12, 2026: HCS Voted Do Pass (H)Sponsor: Brian Seitz

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Health carriers and s must include payments made by or on behalf of an enrollee toward out-of-pocket maximums and requirements for medications lacking a generic substitute, effective August 28, 2026. The legislation also prohibits health plans from varying cost-sharing requirements based on the availability of assistance programs for such medications. Plans covered under the Labor Management Relations Act are exempt from these requirements.

Why it matters

Enrollees utilizing manufacturer coupons or third-party financial assistance for brand-name drugs without generic equivalents will see those payments count directly toward their deductible and out-of-pocket limits, potentially accelerating the point at which insurance covers total costs.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Health plan enrollees

Enrollees using medications without generic substitutes will have third-party payments and copay assistance counted toward their out-of-pocket maximums and deductibles.

Directly affected

Health carriers

Health carriers must modify how they calculate out-of-pocket maximums and cost-sharing requirements for applicable medications in plans renewed or entered into on or after August 28, 2026.

Directly affected

Pharmacy benefits managers

Pharmacy benefits managers are prohibited from adjusting cost-sharing or out-of-pocket maximums based on the availability of cost-sharing assistance programs for drugs lacking generic equivalents.

Key Facts

  • Health carriers and pharmacy benefits managers must count any amounts paid by or for an enrollee for a medication toward out-of-pocket maximums and cost-sharing requirements when no generic substitute is available.
  • Health carriers and pharmacy benefits managers are prohibited from varying an enrollee's out-of-pocket maximum or cost-sharing requirements based on the availability of a cost-sharing assistance program for medications without generic substitutes.
  • For health savings account-qualified high deductible health plans, the counting requirement applies after the enrollee satisfies the minimum deductible under Section 223 of the Internal Revenue Code, except for preventive care items or services where it applies regardless.
  • Health carriers and health benefit plans retain the ability to utilize step therapy in accordance with section 376.2034.
Show all 6 facts
  • Health benefit plans covered under the Labor Management Relations Act of 1947 are exempt from the provisions of this section.
  • The provisions apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026.

Frequently Asked Questions

What triggers the requirement to count third-party payments toward out-of-pocket maximums?
The requirement applies when a payment is made by or on behalf of an enrollee for a medication that does not have an available generic drug substitute.
Are health savings account-qualified high deductible health plans subject to this rule?
Yes, but for HSA-qualified high deductible plans, the requirement applies after the enrollee has satisfied the minimum deductible under Section 223 of the Internal Revenue Code, except for preventive care services where the rule applies immediately.
Which health plans are exempt from these provisions?
Health benefit plans covered under the Labor Management Relations Act of 1947 are exempt from this section.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

8 actions
  1. Feb 12, 2026HouseCommittee
    HCS Voted Do Pass (H)
  2. Feb 12, 2026House
    Executive Session Completed (H)
  3. Feb 12, 2026House
    Public Hearing Completed (H)
  4. Feb 12, 2026HouseCommittee
    HCS Reported Do Pass (H)
  5. Feb 5, 2026HouseCommittee
    Referred: Health and Mental Health(H)
  6. Jan 8, 2026HouseFloor
    Read Second Time (H)
Show 2 earlier actions
  1. Jan 7, 2026HouseIntroduced
    Read First Time (H)
  2. Dec 1, 2025HouseIntroduced
    Prefiled (H)

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Sources

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz25
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record